Global Fish Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fish Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed animals, have an increased susceptibility to infectious diseases. Such diseases may be bacterial, viral, fungal or parasitic in origin. These are the immune foundations for immunizing fish against various diseases.
Fish Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fish Vaccine market is projected to reach US$ 631.5 million in 2034, increasing from US$ 338.6 million in 2022, with the CAGR of 9.2% during the period of 2024 to 2034. Demand from Pangasius and Tilapia are the major drivers for the industry.
The industry's leading producers are Zoetis and Merck & Co., Inc., which accounted for 52.92% and 34.85% of revenue in 2019, respectively.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fish Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Zoetis
Merck & Co., Inc.
Tecnovax
Veterquimica S.A.
HIPRA
Anicon Labor GmbH
Segment by Type
Injectable Vaccines
Dip Vaccines
Oral Vaccine
Pangasius
Tilapia
Salmon
Seabass
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fish Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fish Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fish Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fish Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fish Vaccine introduction, etc. Fish Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Fish Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Fish Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fish Vaccine market is projected to reach US$ 631.5 million in 2034, increasing from US$ 338.6 million in 2022, with the CAGR of 9.2% during the period of 2024 to 2034. Demand from Pangasius and Tilapia are the major drivers for the industry.
The industry's leading producers are Zoetis and Merck & Co., Inc., which accounted for 52.92% and 34.85% of revenue in 2019, respectively.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fish Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Zoetis
Merck & Co., Inc.
Tecnovax
Veterquimica S.A.
HIPRA
Anicon Labor GmbH
Segment by Type
Injectable Vaccines
Dip Vaccines
Oral Vaccine
Segment by Application
Pangasius
Tilapia
Salmon
Seabass
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fish Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fish Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fish Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fish Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fish Vaccine introduction, etc. Fish Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Fish Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.